Home / Publications / Experience & Statistics / Ischaemic heart disease

Ischaemic heart disease

Ischaemic heart diseaseIschaemic heart disease (IHD) confidently remains the leading cause of death in Ukraine. IHD killed 329.3 thousand people (48%) in 2012. Read more at World Health Organization.

According to the data of the MoH, 50,744 cases of acute and repeated myocardial infarction were registered among the adult population in 2013 (135.7 cases per 100,000 population).

Public medical organizations

Standardization of medical care

  • The Order of MoH of Ukraine #455 of 02.07.2014 “On approving and implementation of medical and technical documents on standardization of medical care in acute coronary syndrome with ST-segment elevation”. Read more
  • The Order of MoH of Ukraine #164 of 03.03.2016 “On approving and implementation of medical and technical documents on standardization of medical care in acute coronary syndrome without ST-segment elevation”. Read more

Clinical trials including adults /adults, adults & children/

Globally, there are 663 (incl. 26 Phase I trials) recruiting clinical trials for Ischaemic heart disease at ClinicalTrials.gov. The list of country leaders in the world begins with: the USA – 139, China – 84, Canada/the Republic of Korea – 61 trials.

Ukraine keeps the 10th place among the countries in CEE: 38 clinical sites from 19 sities are participating in 5 recruiting international Phases III and IV clinical trials for IHD. The city leaders in Ukraine: Kharkiv/Kyiv/Vinnytsia/ Zaporizhia – 5 clinical trials.

Medical devices: Globally, there are 205 recruiting clinical trials for IHD including 6 Phase I trials. The country leaders are presented by: the USA – 29, China/Germany – 28, the Republic of Korea/the UK – 18 clinical trials.

Stem cells: Globally, there are 22 recruiting clinical trials for IHD including 8 Phase I trials. The country leaders are following: France – 7, the USA – 4, the UK – 3 clinical trials.

recruiting clinical trials for IHD including adults in Ukraine
recruiting clinical trials for IHD including adults in CEE


Clinical trials including children /pediatric, children & adults/

Globally, there are 30 (incl. 1 Phase I trial) recruiting clinical trials for Ischaemic heart disease at ClinicalTrials.gov. The country leaders are following: the USA – 6, Sweden – 3, Canada/Germany/Greece/ France/the Netherlands – 2 trials. In CEE, the recruiting clinical trials for IHD are being conducted in the Czech Republic/Hungary/Slovenia – 1 clinical trial.

Medical devices: Globally, there are 7 (Phase I – no trials) recruiting clinical trials for IHD: the Republic of Korea – 2, Japan – 1, other countries  – 4 clinical trials totally.

Stem cells: Globally, there is 1 recruiting Phase II clinical trial for IHD conducted in the Islamic Republic of Iran.


Non-interventional studies /adults, adults & children/

Globally, there are 310 recruiting studies for Ischaemic heart disease with the country leaders: the USA – 62, the Republic of Korea – 35, Germany – 33, China – 31 studies. In CEE, Austria and the Czech Republic are leading with 5 studies.

Ukraine: there is 1 recruiting observational study correspondingly.

Medical devices: Globally, there are 58 registered recruiting observational studies for Ischaemic heart disease with the country leaders: the Republic of Korea – 14, Germany – 11, the USA – 9 studies. In CEE, the recruiting observational studies are being conducted in 4 countries: Romania – 2, the Czech Republic/ Hungary/Poland – 1 recruiting study.

Non-interventional studies /pediatric, children & adults/

Globally, there are 36 recruiting studies for Ischaemic heart disease with the country leaders: the USA – 8, China – 6, Italy – 4 studies.

Medical devices: Globally, 2 recruiting studies.

NB! The cities located on the non-controlled territories of Ukraine are not included in the statistics.

Publications of

Sergii Gromov

Leave a Reply